What Kalehua Capital Management LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 2106181 · Filed Nov 13, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
MANEVeradermics, Inc | 145.7K | New | $17.7M | 13.3% |
EA SERIES TRUSTALPHA ARCH 1-3 | 148.5K | New | $17.6M | 13.3% |
| 442.7K |
| New |
| $14.2M |
| 10.7% |
XFORX4 Pharmaceuticals, Inc | 3.7M | ±0% | $10.8M | 8.2% |
ACRSAclaris Therapeutics, Inc. | 1.8M | ±0% | $9.6M | 7.3% |
SRZNSurrozen, Inc. | 286.1K | −25.7% | $9.2M | 7% |
IKTInhibikase Therapeutics, Inc. | 3.8M | ±0% | $7.9M | 5.9% |
SEPNSepterna, Inc. | 194.5K | ±0% | $7.6M | 5.7% |
BETRFBetterLife Pharma Inc. | 27.7M | New | $6.7M | 5% |
OBXObsidian Therapeutics, Inc. | 416.6K | New | $5.7M | 4.3% |
IFRXInflaRx N.V. | 2.9M | +0.8% | $5.3M | 4% |
KRROKorro Bio, Inc. | 473.6K | New | $4.7M | 3.5% |
ATTOAttovia Therapeutics, Inc. | 200K | New | $3.4M | 2.6% |
DMRADamora Therapeutics, Inc. | 139K | New | $3M | 2.2% |
QUREuniQure N.V. | 79.4K | ±0% | $1.9M | 1.4% |
GOSSGossamer Bio, Inc. | 139.4K | New | $1.7M | 1.2% |
MISTMilestone Pharmaceuticals Inc. | 1.7M | +30.1% | $1.4M | 1.1% |
LONALeonaBio, Inc. | 393.7K | ±0% | $1.4M | 1.1% |
RNAAtrium Therapeutics, Inc. | 112.7K | New | $932.8K | 0.7% |
TILInstil Bio, Inc. | 99.6K | ±0% | $721.1K | 0.5% |
ATYRaTYR PHARMA INC | 1.8M | +2.3% | $554.3K | 0.4% |
KZIAKazia Therapeutics Ltd | 56K | New | $537.4K | 0.4% |